ENDRA Life Sciences Inc. (NDRA)
After hours:
| Previous close | 0.2819 |
| Open | 0.2813 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.2813 - 0.3440 |
| 52-week range | 0.2210 - 2.7900 |
| Volume | |
| Avg. volume | 186,200 |
| Market cap | 3.389M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.5800 |
| Earnings date | 12 Aug 2024 - 16 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 10.00 |
- GuruFocus.com
ENDRA Life Sciences Inc (NDRA) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
Discover how ENDRA Life Sciences Inc navigates its financial landscape and strategic milestones amidst ongoing challenges.
- Business Wire
ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update
ANN ARBOR, Mich., May 14, 2024--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the three months ended March 31, 2024 and provided a business update.
- Business Wire
ENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024
ANN ARBOR, Mich., May 07, 2024--ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the company will report financial results for the three months ended March 31, 2024 on Tuesday, May 14, 2024 after the close of trading on the U.S. financial markets. Management will host a conference call and webcast beginning at 4:30 p.m. Eastern time to discuss the results, provide an update on recent corporate developments and answer
